Cutaneous neuroendocrine carcinoma
ORPHA:79140DiseaseNot applicableAdult, Elderly
Фенотипы (HPO)17
Облигатный (100%)1
HP:0030447Merkel cell skin cancer
Частый (30–79%)7
HP:0000992Cutaneous photosensitivity
HP:0002730Chronic noninfectious lymphadenopathy
HP:0005374Cellular immunodeficiency
HP:0011356Regional abnormality of skin
HP:0025474Erythematous plaque
HP:0025475Erythematous macule
HP:0200036Skin nodule
Периодический (5–29%)5
HP:0002671Basal cell carcinoma
HP:0005526Lymphoid leukemia
HP:0006739Squamous cell carcinoma of the skin
HP:0006775Multiple myeloma
HP:0100570Carcinoid tumor
Очень редкий (1–4%)3
HP:0012658Abnormal brain FDG positron emission tomography
HP:0030692Brain neoplasm
HP:0040095Neoplasm of the outer ear
Исключён (0%)1
HP:0012531Pain
Эпидемиология12
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.27 | Worldwide | Value and class |
| Point prevalence | 1-9 / 100 000 | 4 | Europe | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.13 | Europe | Value and class |
| Lifetime Prevalence | 1-9 / 1 000 000 | 0.86 | Europe | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.06 | Finland | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.7 | United States | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.22 | Denmark | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.378 | France | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.13 | United Kingdom | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.8 | Australia | Value and class |
| Annual incidence | 1-9 / 100 000 | 2 | New Zealand | Value and class |
| Annual incidence | 1-9 / 100 000 | 4 | Norway | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)